High Cure Rate for Acute Streptococcal Prosthetic Joint Infections Treated With Debridement, Antimicrobials, and Implant Retention in a Specialized Tertiary Care Center

Kaisa Huotari; Markku Vuorinen; Mikko Rantasalo

doi:10.1093/cid/ciy335

High Cure Rate for Acute Streptococcal Prosthetic Joint Infections Treated With Debridement, Antimicrobials, and Implant Retention in a Specialized Tertiary Care Center

Clin Infect Dis. 2018 Sep 28;67(8):1288-1290. doi: 10.1093/cid/ciy335.

Authors

Kaisa Huotari¹, Markku Vuorinen², Mikko Rantasalo²

Affiliations

¹ Division of Infectious Diseases, Inflammation Center, Finland.
² Department of Orthopedics and Traumatology, Helsinki University Hospital and University of Helsinki, Finland.

PMID: 29684101
DOI: 10.1093/cid/ciy335

Abstract

Streptococcal prosthetic joint infections (PJIs) treated with debridement, exchange of removable parts, antibiotics, and implant retention within 3 weeks from symptom onset had an implant survival rate of 97.9% and an implant survival rate without suppressive antimicrobials of 80.9%. Treatment centralization for acute streptococcal PJIs to specialized centers makes excellent cure rates possible.

MeSH terms

Adult
Aged
Aged, 80 and over
Anti-Bacterial Agents / therapeutic use*
Arthritis, Infectious / drug therapy
Debridement*
Female
Finland
Humans
Male
Middle Aged
Prostheses and Implants
Prosthesis-Related Infections / therapy*
Retrospective Studies
Streptococcal Infections / drug therapy*
Streptococcus / drug effects
Tertiary Care Centers
Young Adult

Substances

Anti-Bacterial Agents